Stuart Duty - 10 Jun 2025 Form 4 Insider Report for Milestone Pharmaceuticals Inc. (MIST)

Role: Director
Signature: /s/ Jason Minio, Attorney-in-Fact
Issuer symbol: MIST
Transactions as of: 10 Jun 2025
Net transactions value: $0
Form type: 4
Filing time: 12 Jun 2025, 16:19:03 UTC
Previous filing: 10 Jun 2025
Next filing: 06 Jan 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Duty Stuart	Director	C/O MILESTONE PHARMACEUTICALS INC., 1111 DR. FREDERIK-PHILIPS BLVD, STE 420, MONTREAL, QUEBEC, CANADA	/s/ Jason Minio, Attorney-in-Fact	12 Jun 2025	0001970274

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MIST	Stock Option (right to buy)	Award	$0	+40,000		$0.000000	40,000	10 Jun 2025	Common Stock	40,000	$1.75	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This option will vest in twelve (12) equal monthly installments, beginning on July 10, 2025, provided that the option will in any case be fully vested on the date of next annual meeting of the stockholders of the Issuer, subject to the Reporting Person continuing to provide service through each such vesting date.